For many years, automation in the clinical microbiology laboratory has lagged behind other laboratory disciplines. Automation has revolutionized the clinical core laboratory, including chemistry, hematology, coagulation, and immunology, with testing instruments connected to tracks and routing conveyors, all managed in precise detail by computer. In contrast, many microbiologists continue to open specimen containers by hand and grow bacteria using incubators, and manually inspect agar plates for bacteria growth with manual follow up. But, this is changing, and new developments in microbiology automation are impacting the way we design and plan microbiology laboratory spaces. The Evolving Microbiology Laboratory Advances in science and technology have led to the development and widespread clinical application of molecular diagnostics, digital microbiology, mass spectrometry (MS), MALDI-TOF, and total laboratory automation (TLA) systems. From an architectural and engineering standpoint, these advances are having a tremendous impact on modern day microbiology laboratory design and build. At Geisinger Health in Danville, Pennsylvania, the laboratory functions with numerous disciplines working together in a large space, and when they had to opportunity to rearrange their microbiology operations, they took a critical eye to both current operations and future plans to adopt automation. Clinical microbiology historically requires intake, management, and output on a diversity of patient specimen types (eg, stool samples, respiratory secretions, etc). Samples arrive in multiple tube variants or on swabs in different sized containers requiring logistical operations. Once specimens are received in micro, a lengthy culturing process may be necessary, including visual inspection before final results can be produced. The considerable variability in the culture process has traditionally hampered standardization—a requirement for automation—but new transport devices have been developed in recent years for certain specimen types that support automation and its attendant benefits, including expedited results and the ability to detect and identify a greater number of organisms faster. As an example, actionable results on flu molecular tests previously required at least multiple days, but are now available in as little as 20 minutes, driving both antiviral and to some extent, antibiotic therapy. The microbiology regulatory environment also has changed in recent years with the FDA approving additional test options, thereby broadening microbiology test menus. (Some of these are FDA-approved directly, whereas others are validated only by individual laboratories; ie, laboratory developed tests or LDTs.) Given that microbiology lab results directly influence not only inpatient management, but also the decisions to admit or isolate a patient, the practice of clinical microbiology must remain on the forefront of patient medical diagnosis and treatment strategies, and therefore requires careful attention to physical operations and clinical workflow. Examine Microbiology Workflow Fundamentally, a keen interpretation of workflow should drive a solid design in all clinical operations. This includes an understanding of intra-laboratory relationships, block planning, and schematic design toward a common goal of efficiency and economy. As such, we can examine the dimensions of workflow in a modern microbiology laboratory moving from general to specific. In this case, Geisinger wanted its three main types of clinical microbiology laboratory practice to work together seamlessly (see FIGURE 1): Stat molecular microbiology (eg, infectious disease molecular diagnostics, rapid MRSA testing, minimum inhibitory testing [MIC], etc) Traditional microbiology including blood cultures (eg, cultures, direct stains, microscopy, antigen testing, etc) Batch molecular microbiology (eg, once a day or once per shift) Click here to view a larger version of this Figure

At a high level, specimens are received, sorted, and routed to one of these three areas of processing. When planning a design, we further break down the workflow as moving from a central receiving and processing (RAP) area to specific processes taking place in the molecular stat laboratory, bacteriology, batch micro-molecular, a biosafety-level 3 laboratory (not discussed in this article), and non-microbiology molecular diagnostics that may share instruments with molecular microbiology.

When considering how these elements work together, the workflow can be illustrated using a more detailed relationship diagram (see FIGURE 2). From this diagram, we can then develop a block plan, wherein function blocks are strategically arranged for each process, sized to represent the workload of the function, and physically placed to best accommodate workflow as demonstrated by arrows (see FIGURE 3).

Click here to view a larger version of this Figure

Outlining Pre-Automation Workflow with Specialty Locations

Beginning with the general laboratory RAP area (sometimes referred to as a clerical or specimen accessioning area) where all lab specimens are received, accessioned, and divided into the various disciplines in the lab, we see that specimens arrive in various containers, frequently with a coolant, and some of these containers must be returned. The specimens are then commonly moved to a general separation area and sorted with the microbiology specimens sent to the micro RAP area and on to the appropriate microbiology workspaces (see FIGURE 4). Other specimens are sent to their appropriate laboratory section. Within microbiology, there are smaller, adjacent labs for operations specific to stat molecular diagnostics and blood cultures. These smaller labs must work in harmony with the main microbiology processing lab.

Click here to view a larger version of this Figure

Molecular Stat Lab

The stat micro-molecular laboratory, which is located adjacent to the general laboratory RAP area for efficient specimen transport, is illustrated in FIGURE 5. Once specimens are received, they are loaded onto the instruments for infectious disease molecular diagnostics, rapid MRSA testing, and minimal inhibitory concentrations (MIC) for positive blood cultures, among other determinations. By using this combination of instrumentation in an open and collaborative setting, most results are produced in two hours or fewer and can be communicated to clinicians for treatment decisions and to facility operations (via a bed management dashboard) for admission, isolation, or discharge decisions.

Click here to view a larger version of this Figure

Blood Cultures Lab

Pre-inoculated blood cultures are routed directly from the Micro RAP work stations to the blood cultures laboratory where they are loaded on to instruments for incubation (see FIGURE 6). These results are made available in as little as 6-24 hours of bacteria discovery (some results may take longer) and negative cultures are incubated here for a total of five days. Positive blood cultures are moved to the stat molecular area for testing and processing, including Gram staining before being incubated and routed to bacteriology.

Click here to view a larger version of this Figure

Future Planning for Automation

In the traditional bacteriology laboratory, specimens are manually moved to incubators in one area of the bacteriology laboratory, then to manual workstations in another area. These workstations attend to several specimen types, including urines, wound swabs, respirators, anerobes, ganstrointestial, etc. From these workstations, specimens are sent to identification stations, MALDI-TOF MS and to antimicrobial susceptibility testing (AST) areas, as well as Kirby-Bauer (disk diffusion) testing, and so on. However, in a TLA system, specimens are placed on a conveyor and delivered to a number of workstations for automated plate streaking, incubation, and digital imaging of culture colonies.

The microbiology laboratory at Geisinger was initially designed to accommodate manual work ups at workstations distributed along a narrow corridor, but which would also accommodate a TLA system at a later date without major changes to the laboratory space.

Automation Arrangement

The new TLA workflow system housed in the main microbiology laboratory at Geisinger will comprise six modules:

Media storage and distribution Bar code identification Inoculation Two-way conveyor linking all modules Normal incubation and CO 2 incubation, with digital imaging Workbenches

FIGURE 7 shows the current-state microbiology laboratory with a passageway between the work stations intended to accommodate the forthcoming conveyor and associated automation system, as well as an illustration of the resulting TLA system. Block planning this modern microbiology laboratory begins with the two-way conveyor in the middle with workstations 1, 2, and 6 located on either side of the conveyor (see FIGURE 8). Note that the work stations for MALDI-TOF and AST areas are both located just to the right of the conveyors, allowing for those stations to attach to the conveyor system if deemed beneficial.

Like the stat molecular and blood cultures labs, the general micro-molecular lab is located adjacent to the main microbiology lab at the rear (see FIGURES 9 and 10). This molecular laboratory is designed to accommodate PCR technology in a uni-directional workflow that includes a reagent preparation room and a separate sample preparation room. This separation is necessary to prevent the reagents from being contaminated by patient samples. Note that both the sample prep and reagent prep labs have separate entrances, and both have entrances to the amplification and detection lab.

Conclusion

The trend toward incorporating automation lines into microbiology practice has been supported by novel robotics, advancements in molecular diagnostics, digital imaging, and mass spectrometry. With the modularity afforded by the TLA system, Geisinger plans to incorporate AST and MALDI-TOF functions into the automation line.

In the past, the diverse nature of microbiology specimens paired with lengthy and manual culturing processes and human review hindered the standardazation required for automation to be effective. However, breakthroughs in molecular diagnostics are changing the limitations on standardization and automation in microbiology and allowing the laboratory to identify more pathogens faster without many of the impediments of past culturing processes. Treatment can now begin as soon as a pathogen is identified, eliminating lost time and effort spent utilizing broad spectrum and sometimes ineffective antibiotics. Microbiology is no longer focused on confirmatory testing, but is engaged in the mainstream of lab workflow and should be designed at the forefront of specimen delivery. This physical structuring has important implications for planning and designing the laboratory space. Microbiology can no longer be located away from the center of the laboratory in disparate areas; rather it should be afforded a prominent place in your laboratory space.

Ted Newell, AIA, NCARB, AABB, is an architect and principal at Ted Newell, Architect and Planner, in West Chester, Pennsylvania. He is a laboratory design innovator with over 30 years’ experience and leadership in the programming, planning, and design of complex facilities for clinical and anatomic pathology facilities. Ted interacts extensively with each client and key project stakeholders to design lab spaces and places.

Donna M. Wolk, MHA, PhD, (D(ABMM), is division director of molecular and microbial diagnostics and development at Geisinger, Diagnostic Medicine Institute headquartered in Danville, Pennsylvania. She serves on the Clinical Laboratory Improvement Advisory Committee (CLIAC) managed by the CDC, to provide scientific and technical guidance to the US DHHS. Dr. Wolk also is the lead investigator for Geisinger’s Center for Laboratory Innovations and Outcomes, and chair of the Diagnostic Medicine Institute’s Clinical Research Council.

FOR MORE INFO ON LAB DESIGN

Clinical Laboratory Design Concepts Theodore R. Newell, AIA, NCARB, AABB

medlabmag.com/DesignConcepts Evolving Workflow Drives Anatomic Pathology Design Sandy Mullay, BS, MT(ASCP); Theodore R. Newell, AIA, NCARB, AABB;

Jeffrey Prichard, DO, FCAP; Sara Eastman, AIA

medlabmag.com/pathology_design Clinical Core Lab Design: From Looking Up to Looking Down Tammy Germini, MT(ASCP); Theodore R. Newell, AIA, NCARB, AABB;

Sara Eastman, AIA

medlabmag.com/core_design